ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,601,792 | +2215.3% | 268,800 | +1990.9% | 0.13% | +2580.0% |
| Q1 2023 | $241,950 | -73.8% | 12,856 | -77.9% | 0.01% | -76.2% |
| Q4 2022 | $925,095 | -2.7% | 58,109 | 0.0% | 0.02% | -12.5% |
| Q3 2022 | $951,000 | +101.5% | 58,109 | +104.4% | 0.02% | +84.6% |
| Q3 2021 | $472,000 | -45.7% | 28,434 | -20.2% | 0.01% | -53.6% |
| Q2 2021 | $869,000 | +93.5% | 35,627 | +104.7% | 0.03% | +64.7% |
| Q1 2021 | $449,000 | +45.3% | 17,402 | +201.0% | 0.02% | +54.5% |
| Q4 2020 | $309,000 | +12.4% | 5,781 | -13.4% | 0.01% | -35.3% |
| Q3 2020 | $275,000 | -11.0% | 6,672 | -55.2% | 0.02% | -45.2% |
| Q3 2018 | $309,000 | – | 14,893 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |